PredictSURE IBD™


  • Validated, CE-marked prognostic test for guiding treatment options
  • Biomarker test

About PredictSURE IBD™

Award-winning PredictSURE IBD™, made by PredictImmune, is the world’s first validated and CE-marked prognostic test for guiding treatment options in inflammatory bowel disease (Crohn’s disease and ulcerative colitis).

PredictSURE IBD™ is based upon 10 years of extensive research on gene expression profiling of CD8+ T cells. This whole blood-based biomarker test is a major step towards personalised medicine in IBD.

PredictSURE IBD™ is an easy-to-set-up biomarker test for doctors to use, combined with a sophisticated, proprietary algorithm that will tell you the likely course of your newly diagnosed patients’ IBD; differentiating between an aggressive or milder form of the disease. All you need is a small blood sample (16+ years) and an on-line account for rapid, on-line reporting. With PredictSURE IBD™ you can take control of Crohn’s disease and ulcerative colitis treatment options.

Find this article useful?

Why not sign up to our mailing list and receive regular articles and tips about IBD to your inbox?